{"id":1662,"date":"1999-08-01T12:06:00","date_gmt":"1999-08-01T10:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/leserbrief-laktatazidosen-unter-metformin"},"modified":"1999-08-01T12:06:00","modified_gmt":"1999-08-01T10:06:00","slug":"leserbrief-laktatazidosen-unter-metformin","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1999\/leserbrief-laktatazidosen-unter-metformin","title":{"rendered":"Leserbrief: Laktatazidosen unter Metformin"},"content":{"rendered":"<p>Frage von Dr. W.K. aus Berlin: >> Eine 66j\u00e4hrige, somnolente Patientin wurde mit akutem Nierenversagen und Hypothermie (32,8 \u00b0C) aufgenommen. RR 100\/30 mmHg, Puls 97\/ Min., zentraler Venendruck +18 cm H2O. Einige Laborwerte: pH arteriell: 6,75, BE -30 mmol\/l, Kreatinin 9,6 mg\/dl, Laktat 32,1 mmol\/l, Blutzucker 125 mg\/dl, Kalium 5,9 mmol\/l. Keine Sepsis, kein Leberversagen, [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Frage von Dr. W.K. aus Berlin: >> Eine 66j\u00e4hrige, somnolente Patientin wurde mit akutem Nierenversagen und Hypothermie (32,8 \u00b0C) aufgenommen. RR 100\/30 mmHg, Puls 97\/ Min., zentraler Venendruck +18 cm H2O. Einige Laborwerte: pH arteriell: 6,75, BE -30 mmol\/l, Kreatinin 9,6 mg\/dl, Laktat 32,1 mmol\/l, Blutzucker 125 mg\/dl, Kalium 5,9 mmol\/l. Keine Sepsis, kein Leberversagen, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[155,3806,1730,157],"class_list":["post-1662","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-diabetes-mellitus-typ-2","tag-laktatazidose","tag-metformin","tag-orale-antidiabetika"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1662"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1662\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}